Metaxalone
NDC 69097-998, Metaxalone, tablet, from CIPLA USA INC..
- Product NDC
- 69097-998
- Status
- Listed
- Labeler
- CIPLA USA INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207466
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-998 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METAXALONE400 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-998-07 | 69097099807 | 100 TABLET in 1 BOTTLE (69097-998-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c1f49112-e8ce-43a9-bdb8-1a3db4fb6bc4NADAC price for package 69097099807
GET /v1/drugs/nadac/69097099807
Use it
Look up 69097-998 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-998 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-998. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.